Proinflammatory signaling in Ewing sarcoma is driven by retroelement activity and counteracted by reverse transcriptase inhibitors.
- DOI
- 10.1016/j.celrep.2026.117708
- Published
- 2026 Jul 28
- Container
- Cell reports
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.celrep.2026.117708,
title = {Proinflammatory signaling in Ewing sarcoma is driven by retroelement activity and counteracted by reverse transcriptase inhibitors.},
author = {Evdokimova V and Ruzanov P and Gassmann H and Hung M and Zhang Z and Senff-Ribeiro A and Khoshgoo N and Zheng S and Pachva MC and Ringwalt EM and Cripe TP and Roberts RD and Sorensen PH and Burdach SEG and Stein LD and Radvanyi L},
year = {2026},
journal = {Cell reports},
doi = {10.1016/j.celrep.2026.117708},
url = {https://doi.org/10.1016/j.celrep.2026.117708}
}RIS
TY - JOUR TI - Proinflammatory signaling in Ewing sarcoma is driven by retroelement activity and counteracted by reverse transcriptase inhibitors. AU - Evdokimova V AU - Ruzanov P AU - Gassmann H AU - Hung M AU - Zhang Z AU - Senff-Ribeiro A AU - Khoshgoo N AU - Zheng S AU - Pachva MC AU - Ringwalt EM AU - Cripe TP AU - Roberts RD AU - Sorensen PH AU - Burdach SEG AU - Stein LD AU - Radvanyi L PY - 2026 JO - Cell reports DO - 10.1016/j.celrep.2026.117708 UR - https://doi.org/10.1016/j.celrep.2026.117708 ER -
APA
V, E., P, R., H, G., M, H., Z, Z., A, S., N, K., S, Z., MC, P., EM, R., TP, C., RD, R., PH, S., SEG, B., LD, S., & L, R. (2026). Proinflammatory signaling in Ewing sarcoma is driven by retroelement activity and counteracted by reverse transcriptase inhibitors.. Cell reports. https://doi.org/10.1016/j.celrep.2026.117708
Source records
- pubmed · retrieved 2026-09-26T12:22:27.665Z